SIGLEC-5/14 Inhibits CD11b/CD18 Integrin Activation and Neutrophil-Mediated Tumor Cell Cytotoxicity.
Bouti P, Blans C, Klein BJAM, Shome D, Nadafi R, Van Houdt M, Schornagel K, Verkuijlen PJJH, Roos V, Reijmers RM, Van Bruggen R, Kuijpers TW, Matlung HL.
Bouti P, et al. Among authors: van houdt m.
Int J Mol Sci. 2023 Dec 5;24(24):17141. doi: 10.3390/ijms242417141.
Int J Mol Sci. 2023.
PMID: 38138970
Free PMC article.